Pages that link to "Q44243764"
Jump to navigation
Jump to search
The following pages link to Methotrexate-induced congenital malformations (Q44243764):
Displaying 50 items.
- Congenital malformations of the central nervous system in rats produced by maternal zinc deficiency (Q23915399) (← links)
- Pattern of response of intact drosophila to known teratogens (Q23919791) (← links)
- Congenital Abnormalities and Anticonvulsant Drugs (Q24683057) (← links)
- Treatment of pregnant women with a diagnosis of inflammatory bowel disease (Q28067821) (← links)
- Anti-inflammatory and immunosuppressive drugs and reproduction (Q28218219) (← links)
- Protein instability and functional defects caused by mutations of dihydro-orotate dehydrogenase in Miller syndrome patients (Q28274852) (← links)
- The hazard evaluation system and information service: a physician's resource in toxicology and occupational medicine (Q28367423) (← links)
- Developmental delay in fetal aminopterin/methotrexate syndrome (Q28369452) (← links)
- Expression and activity of the DNA repair enzyme uracil DNA glycosylase during organogenesis in the rat conceptus and following methotrexate exposure in vitro (Q28573421) (← links)
- Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data (Q31044246) (← links)
- Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy (Q33748043) (← links)
- Contraception for adolescents with lupus. (Q33813399) (← links)
- Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy (Q33829396) (← links)
- Further case of aminopterin syndrome sine aminopterin in a Spanish child (Q34144186) (← links)
- Cancer chemotherapy and pregnancy (Q34331656) (← links)
- Teratology: principles and practice (Q34412699) (← links)
- Abortion induced with methotrexate and misoprostol (Q34713397) (← links)
- Species sensitivities and prediction of teratogenic potential (Q35035971) (← links)
- Use of methotrexate in juvenile idiopathic arthritis (Q35070936) (← links)
- Prevention of congenital abnormalities by periconceptional multivitamin supplementation (Q35188572) (← links)
- Environmental teratogens (Q35662122) (← links)
- Mechanisms of action of teratogenic drugs (Q35667218) (← links)
- Fetal Renal Insufficiency Following Trastuzumab Treatment for Breast Cancer in Pregnancy: Case Report und Review of the Current Literature (Q35789387) (← links)
- Dermatologic drugs in pregnancy (Q36552748) (← links)
- Teratology in Pediatric Practice (Q36760464) (← links)
- Considering the Embryopathogenesis of VACTERL Association (Q36802389) (← links)
- A risk assessment of topical tretinoin as a potential human developmental toxin based on animal and comparative human data (Q36852561) (← links)
- Etiopathogenesis of Craniosynostosis (Q37062965) (← links)
- Inflammatory bowel disease and pregnancy: report of two cases treated with infliximab and a review of the literature (Q37776632) (← links)
- Treatment of inflammatory bowel disease and pregnancy: a review of the literature (Q37780963) (← links)
- Effect of environmental agents on pregnancy outcomes: disturbances of prenatal growth and development (Q37910848) (← links)
- Paediatric outcomes following in utero exposure to the diagnosis and treatment of maternal malignancy (Q37937870) (← links)
- Cancer chemotherapeutic agents as human teratogens (Q38031187) (← links)
- IBD medications during pregnancy and lactation. (Q38125114) (← links)
- The pathologist's perspective of genetic disease. Malformations and dysmorphology (Q38599534) (← links)
- Potential human developmental toxicants and the role of animal testing in their identification and characterization (Q38625359) (← links)
- Chemical-biological reactions common to teratogenesis and mutagenesis (Q39139337) (← links)
- Abortion induced with methotrexate and misoprostol: a comparison of various protocols (Q39443615) (← links)
- Methotrexate in psoriasis: revised guidelines (Q39514650) (← links)
- Iatrogenic Complications of Dermatologic Therapy: Primum non Nocere (Q39544351) (← links)
- Mechanism of known environmental teratogens: drugs and chemicals. (Q39745303) (← links)
- Effect of Drugs on Intrauterine Growth (Q39806262) (← links)
- Dermatologic uses of methotrexate in children: indications and guidelines (Q39818932) (← links)
- Proceedings: Hazards of maternally administered drugs (Q39874417) (← links)
- Antineoplastic and immunosuppressive drugs. 3. Adverse effects and therapeutic problems (Q39923131) (← links)
- Present status of drugs as teratogens in man (Q39924776) (← links)
- Anticonvulsants During Pregnancy: A Danger to the Developing Fetus? (Q39939625) (← links)
- Drug reactions and interactions (Q39994054) (← links)
- Fetal Drug Exposure—Behavioral Teratogenesis (Q40109250) (← links)
- Gestational carcinoma of the female breast (Q40134963) (← links)